Everolimus plus octreotide long-acting repeatable for the treatment of advanced neuroendocrine tumours associated with carcinoid syndrome (RADIANT-2): a randomised, placebo-controlled, phase 3 study
Marianne Pavel(Charité - Universitätsmedizin Berlin), John D. Hainsworth(Sarah Cannon), Éric Baudin(Institut Gustave Roussy), Marc Peeters(Antwerp University Hospital), Dieter Hörsch(Ochsner Medical Center), Robert Winkler(Novartis (United States)), Judith Klimovsky(Novartis (United States)), David Lebwohl(Novartis (United States)), Valentine Jehl(Novartis (Switzerland)), Edward M. Wolin(Cedars-Sinai Medical Center), Kjell Öberg(Uppsala University Hospital), Eric Van Cutsem(Universitair Ziekenhuis Leuven), James C. Yao(The University of Texas MD Anderson Cancer Center)
Cited by 1,050
Abstract
Related Papers
No related papers found
Powered by citation graph analysis